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________________________________________________________________________ 
Eliminating barriers to adequate pain control and decreasing disparities in the 
management of pain is increasingly on the international health policy radar. The 
World Health Organization’s (WHO) published guidelines for physicians and 
pharmacists regarding administration of pain treatment have been adopted by 
professional provider associations world wide.1 The WHO Collaborating Center for 
Policy and Communications in Cancer Care works internationally with governmental 
and nongovernmental organizations and individuals to decrease barriers to pain relief 
through active demonstrations, networking, and policy initiatives. In 2003, legislation 
was introduced (H.R.1863) to recognize pain as a priority health problem in the 
United States. The “National Pain Care Policy Act” calls for the establishment of a 
National Center for Pain and Palliative Care Research at the National Institutes 
of Health and the development of six regional pain research centers throughout the 
country. At the level of patient care, The Joint Commission on Accreditation of 
Healthcare Organizations (JCAHO) has clearly addressed the imperative for 
accredited hospitals and other healthcare settings to competently assess and 
manage pain.2
The Einstein Center for Urban Health Policy and Research and the Einstein Cancer 
Center in Philadelphia are collaborating on a project, funded by the Nathan 
Cummings Foundation, to address barriers to optimal pain control for low to 
moderate income patients with cancer pain.3 Patients with moderate to severe pain 
are identified from their self-rated pain scores Consenting patients are interviewed in 
greater depth about their level of pain and their beliefs and attitudes towards pain.  
Eligibility for relevant pharmaceutical ‘safety net’ programs, which provide vouchers 
for the necessary medication, is also assessed at this time. A nurse program 
manager is available to provide education and counseling to participants when issues 
are identified during the assessment phase. 
 
To date, 40 patients have been enrolled in the program.  Primary patient attitudinal 
beliefs related in the under treatment of pain include: the well-documented fear of 
addiction; fear that pain is a sign of disease progression, which results in their not 
wanting to talk about it with their physician; troubling side effects such as 
constipation; and the desire to save medication for when they “really need it.” 
Fifteen (38 %) participants reported not having the financial ability to pay for their 
medications. Co-payments were reported from a low of $6.00 a prescription to a high 
of $87.00 per prescription. For patients covered by Medicaid, there can be monthly 
caps on number of pills and refills, and prescriptions.4 Even other insurance plans 
can cause similar barriers to receiving appropriate pain treatment, including different 
coverage for pain medications with modest to substantial co-payments, and other 
limitations for non-hospitalized, community dwelling patients. 
 
An important objective of the collaborative project is to facilitate enrollment for these 
patients into pharmaceutical safety net programs. Application processes for 
these programs often require extensive documentation that can challenge even the 
seasoned health professionals. We discovered that safety net programs offered by 
the pharmaceutical companies that produce the most commonly prescribed long 
acting opiods were available only to the uninsured, or had been discontinued 
because a generic form of the drug had become available. Because our low-income 
patients were covered by Medicaid or were Medicaid eligible, the pharmaceutical 
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safety net programs were not available to them. Our interim finding that safety net 
programs were not an option for our patients led us to explore the potential use of 
Methadone, a highly effective, low cost analgesic. Although Methadone has been 
used successfully in severe pain, close supervision and dosage adjustment is 
required and it is not clear that this is a viable option for our patient population at 
this time.  The program continues to consider other options and works towards 
reducing the existing barriers to pain control for those with limited income. It is clear 
that Medicaid must reevaluate current caps and other limitations related to 
prescription pain medication. Other initiatives to allow patient access to needed 
pain medications are crucial to reaching pain management goals.  Additionally, we 
find that counseling patients on attitudinal barriers is an important and often 
neglected component of the field of pain management. 
 
Pain policies and guidelines emphasize pain as a profound human experience. The 
clinical application of pain policies requires continued efforts at multiple levels to 
ensure we meet our humanitarian obligation as health care providers to assess 
and manage pain optimally across all patient populations.  
 
For more information about our program, contact phippst@einstein.edu. 
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